Heart & Vascular Offers the INARI FlowTriever for Treatment of Select High-Risk Patients with Pulmonary Embolism
Hattiesburg Clinic Heart & Vascular is proud to offer a new treatment option for select high-risk patients with pulmonary embolism (PE). The INARI FlowTriever is the first FDA-approved mechanical thrombectomy device indicated for the treatment of pulmonary embolism.
Acute PE is the most common cause of preventable death that occurs in hospitalized patients, according to heart.org, and the third most common cause of cardiovascular death, according to the American College of Cardiology.
Pulmonary embolism is caused by blood clots that travel to the lungs from deep veins in the legs or, more rarely, from other parts of the body. For most low-risk patients with PE, treatment with anti-coagulation medication or “blood thinners” alone is sufficient. However, for patients with high-risk clinical features and a significant clot burden, more aggressive therapy may be beneficial.
“The FlowTriever system is a valuable option in effectively treating pulmonary embolism,” Adam Harless, MD, said. “This new treatment modality does not require open surgery or the use of stronger blood thinners, known as thrombolytics, and can safely remove an extensive amount of clot from the pulmonary arteries in a short, single-session procedure without the need for general anesthesia.”
The FlowTriever procedure is performed via venous access in a cardiac catheterization lab utilizing an over-the-wire system designed to remove the clot through mechanical and aspiration mechanisms of action. There is often no need for post-procedural ICU admission, which means the patient can return to the hospital floor, reducing the overall length of stay and hospital cost.
The FlowTriever procedure is offered by the interventional cardiologists at Hattiesburg Clinic Heart & Vascular. For more information or to see if you qualify for this procedure, contact Hattiesburg Clinic Heart & Vascular at (601) 268-5800.
About Heart & Vascular
Heart & Vascular provides diagnostic and therapeutic services and surgical procedures for patients with all types of cardiac disorders. Areas of focus include: Hospital Services, Cardiothoracic Surgery, Cardiac Electrophysiology, Interventional Cardiology, Structural Cardiology, Peripheral Vascular Interventions, Disease Management, Diagnostic Services, and Vascular Services.
The combined capabilities of the staff provide expertise for invasive and noninvasive studies using angiography, angioplasty, echocardiography, nuclear cardiology, electrocardiography, hemodynamic assessment, and electrophysiology.